WINDTREE THERAPEUTICS INC /DE/ Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Windtree Therapeutics Inc /De/ quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Windtree Therapeutics Inc /De/ Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 592K shares, a 88.5% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 592K -4.56M -88.5% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 510K -399K -43.9% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 333K -439K -56.9% Dec 31, 2023 10-Q 2024-08-19
Q3 2023 5.15M -27.5M -84.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 5.15M -24.3M -82.5% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 909K -27.6M -96.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 772K +207K +36.6% Dec 31, 2022 10-K 2024-04-16
Q3 2022 32.6M +5.94M +22.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 29.4M +2.7M +10.1% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 28.5M +2.21M +8.43% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 565K -16.4M -96.7% Dec 31, 2021 10-K 2023-03-31
Q3 2021 26.7M +9.78M +57.8% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 26.7M +9.84M +58.3% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 26.3M +12.6M +91.7% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 16.9M +3.22M +23.5% Dec 31, 2020 10-K 2022-03-31
Q3 2020 16.9M -15.3M -47.4% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 16.9M -15.3M -47.6% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 13.7M -18.5M -57.4% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 13.7M -18.4M -57.4% Dec 31, 2019 10-K 2021-03-29
Q3 2019 32.2M +28.4M +754% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 32.2M +28.4M +754% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 32.2M +29M +897% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 32.1M +28.9M +896% Dec 31, 2018 10-K 2020-04-03
Q3 2018 3.77M -11.8M -75.7% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 3.77M -6.8M -64.3% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 3.23M -6.36M -66.3% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 3.23M +2.79M +640% Dec 31, 2017 10-K/A 2019-04-23
Q3 2017 15.5M +7.07M +83.4% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 10.6M +2.28M +27.5% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 9.59M +1.36M +16.5% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 436K -7.76M -94.7% Dec 31, 2016 10-K 2018-04-17
Q3 2016 8.48M -104M -92.4% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 8.29M -77.6M -90.4% Jun 30, 2016 10-Q 2016-08-10
Q1 2016 8.23M -77.5M -90.4% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 8.19M +2.08M +34% Dec 31, 2015 10-K 2017-03-31
Q3 2015 112M +26.7M +31.3% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 85.9M +710K +0.83% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 85.7M +696K +0.82% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 6.11M -78.5M -92.8% Dec 31, 2014 10-K/A 2016-03-29
Q3 2014 85.3M +30.4M +55.4% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 85.2M +30.4M +55.5% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 85.1M +41.3M +94.3% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 84.6M +41M +93.9% Dec 31, 2013 10-K 2015-03-16
Q3 2013 54.9M +11.4M +26.2% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 54.8M +11.3M +26.1% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 43.8M +43.7M +100831% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 43.7M +19.1M +77.6% Dec 31, 2012 10-K 2014-03-17
Q3 2012 43.5M +43.5M Sep 30, 2012 10-Q 2012-11-14
Q2 2012 43.4M +43.4M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 43.4K Mar 31, 2012 10-Q 2012-05-15
Q4 2011 24.6M +10.8M +78.1% Dec 31, 2011 10-K 2013-03-15
Q3 2011 24.3K* Sep 30, 2011 10-Q 2011-11-14
Q2 2011 24.2K* Jun 30, 2011 10-Q 2011-08-15
Q4 2010 13.8M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.